CONTOLI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 12.085
AS - Asia 6.060
EU - Europa 3.929
SA - Sud America 1.070
AF - Africa 106
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 23.282
Nazione #
US - Stati Uniti d'America 11.845
SG - Singapore 2.677
CN - Cina 1.520
IT - Italia 1.026
BR - Brasile 882
DE - Germania 753
HK - Hong Kong 628
UA - Ucraina 489
VN - Vietnam 420
GB - Regno Unito 349
TR - Turchia 318
FI - Finlandia 308
SE - Svezia 231
PL - Polonia 199
RU - Federazione Russa 187
ID - Indonesia 156
MX - Messico 129
FR - Francia 108
CA - Canada 92
IN - India 87
AR - Argentina 84
NL - Olanda 75
BD - Bangladesh 56
JP - Giappone 54
ZA - Sudafrica 53
ES - Italia 39
LT - Lituania 31
AT - Austria 30
IQ - Iraq 29
BE - Belgio 28
PY - Paraguay 22
CZ - Repubblica Ceca 21
EC - Ecuador 21
AU - Australia 18
CO - Colombia 18
KR - Corea 18
PK - Pakistan 14
MA - Marocco 12
UZ - Uzbekistan 12
PE - Perù 11
VE - Venezuela 11
CL - Cile 9
UY - Uruguay 9
TN - Tunisia 8
KE - Kenya 7
AL - Albania 6
DZ - Algeria 6
JO - Giordania 6
NZ - Nuova Zelanda 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
HU - Ungheria 5
IR - Iran 5
TW - Taiwan 5
CH - Svizzera 4
ET - Etiopia 4
EU - Europa 4
GE - Georgia 4
IE - Irlanda 4
IL - Israele 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MK - Macedonia 4
MY - Malesia 4
RO - Romania 4
RS - Serbia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 23.264
Città #
Singapore 1.510
Ashburn 1.271
Fairfield 1.248
Woodbridge 1.044
Houston 970
Santa Clara 625
Hong Kong 624
Jacksonville 559
Chandler 537
Ann Arbor 508
Beijing 506
Seattle 494
Wilmington 493
Cambridge 427
Munich 376
Los Angeles 241
Dallas 203
New York 195
Ferrara 187
Izmir 187
Warsaw 186
Nanjing 177
Princeton 169
Milan 150
Ho Chi Minh City 147
Jakarta 129
Helsinki 122
San Diego 104
Chicago 94
Boardman 89
Hanoi 87
Shanghai 86
São Paulo 86
Mexico City 82
Addison 64
London 58
Turku 57
Dearborn 55
Nanchang 50
Shenyang 48
Rome 47
Tokyo 46
Tianjin 43
Hefei 42
Bologna 39
Buffalo 38
Brooklyn 37
Mountain View 35
Toronto 35
Washington 35
Atlanta 33
The Dalles 33
Denver 32
Changsha 31
Frankfurt am Main 31
Moscow 31
Hebei 30
Boston 29
Jiaxing 29
Orem 29
Redwood City 28
Council Bluffs 27
Nuremberg 27
San Francisco 27
Brussels 26
Chennai 26
Da Nang 26
Falls Church 26
Johannesburg 25
Montreal 25
Rio de Janeiro 23
Salt Lake City 23
Stockholm 23
Amsterdam 22
Jinan 22
Norwalk 22
Phoenix 21
Ankara 19
Bremen 19
Columbus 19
San Jose 19
Guangzhou 18
Lappeenranta 18
Orange 18
Falkenstein 17
Poplar 17
Dong Ket 16
Kunming 16
Manchester 16
Belo Horizonte 15
Brno 15
Taizhou 15
Verona 15
Zhengzhou 15
Baghdad 14
Campinas 14
Dhaka 14
Gangbuk-gu 14
Brasília 13
Haiphong 13
Totale 15.738
Nome #
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 386
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 325
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 317
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 301
Targeting Th2 cells in asthmatic airways 277
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 268
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 264
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 240
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 231
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 230
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 229
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 220
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 217
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 207
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 206
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 203
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 200
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 196
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 192
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 192
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 191
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 185
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 178
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 176
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 175
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 174
Models of infection and exacerbations in COPD. 173
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 173
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 173
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 173
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 172
A serum proteome signature to predict mortality in severe COVID-19 patients 168
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 167
Rhinovirus vaccination: the case against 166
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 164
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 163
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 160
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 159
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 159
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 157
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 157
Cellule staminali e patologia polmonare dell’adulto 155
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 155
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 154
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 154
Asthma: A Chronic Infectious Disease? 152
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 147
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 146
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 145
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 145
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 141
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 141
Interactions of airway pathogens and inflammatory processes 140
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 139
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 139
A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD: A proposal for COPD management 139
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 138
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 137
When asthma diagnosis becomes a challenge 136
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 136
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 136
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 134
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 133
Small airway disease in asthma: pathophysiological and diagnostic considerations 132
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients 132
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 131
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 131
From intensive care to rehabilitation: survey on the satisfaction with care received during prolonged hospitalization for COVID-19 at a northern Italian university hospital 130
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 130
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 130
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 129
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 128
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 127
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study 127
Pathophysiology of viral-induced exacerbations of COPD 126
Mechanisms of respiratory virus-induced asthma exacerbations 126
null 126
Do small airway abnormalities characterize asthma phenotypes? In search of proof. 125
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 125
Interactions of airway pathogens and inflammatory processes 125
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease 124
Increased deposition of activated complement in peripheral lung vessels of smokers 124
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 124
Deficient immune response to viral infections in children predicts later Asthma persistence 124
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 123
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 123
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 122
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 121
Rhinovirus-induced bronchial mucosal inflammatory response in asthma 121
null 121
Disease awareness in patients with COPD: measurement and extent 121
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 120
γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations. 120
Neutrophil adhesion molecules in experimental rhinovirus infection in COPD. 120
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 120
Rhinovirus-induced interferon production in asthma 119
Effects of Anti-IL-5 on Virus-induced Exacerbation in Asthma Light and Shadow 119
Diffuse panbronchiolitis as parathymic syndrome in a Caucasian man previously treated for thymoma 119
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 116
Totale 16.273
Categoria #
all - tutte 122.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.899
Totale 126.845


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.382 0 0 0 0 0 181 103 261 74 305 266 192
2021/20221.529 74 125 108 140 56 80 85 98 65 116 160 422
2022/20231.438 185 62 69 145 205 192 107 117 174 26 104 52
2023/2024980 74 107 48 29 59 170 38 68 34 34 49 270
2024/20254.690 100 107 363 166 530 446 208 290 833 523 596 528
2025/20266.586 1.084 493 1.032 1.460 1.910 607 0 0 0 0 0 0
Totale 23.699